Do you have any statistics or links to support your theory that the USPTO uses terms like "real" vs "fake" based on a company's choice to 1) pay more money to Register a Trademark, or 2) establish protection through the cheaper alternative known as the "Common Law Trademark"?
P.S. I don't invest in real pharmaceutical companies. OWCP is my fave cannabis biopharma because they don't use fake marijuana.